Cargando…
An Integrative Analysis of the Immune Features of Inactivated SARS-CoV-2 Vaccine (CoronaVac)
Currently, an inactivated vaccine has been widely used with encouraging results as a prophylactic agent against COVID-19 infection, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. However, in vitro SARS-CoV-2 vaccine-specific immune features remain e...
Autores principales: | Jiang, Zhujun, Lin, Haishuang, Zhang, Haoran, Shi, Ningning, Zheng, Zhetao, Dong, Liangzhen, Yang, Yuelin, Xia, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231306/ https://www.ncbi.nlm.nih.gov/pubmed/35746486 http://dx.doi.org/10.3390/vaccines10060878 |
Ejemplares similares
-
Effectiveness of inactivated SARS-CoV-2 vaccine (CoronaVac) on intensive care unit survival
por: Sevinc, Sultan Acar, et al.
Publicado: (2022) -
Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging
por: Elverici, Eda, et al.
Publicado: (2023) -
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine
(CoronaVac) in inadvertently vaccinated healthy children
por: Fernandes, Eder Gatti, et al.
Publicado: (2021) -
CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2
por: Jin, Lairun, et al.
Publicado: (2022)